Patent US3875012A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3875012A Expired / Lapsed US ⏱️ 0.0 years remaining

Apparatus and method for the detection of microbial pathogens

Assignee: J K AND SUSIE L WADLEY RESEARCH INSTITUTE AND BLOOD BANK
•
Filing: 1974-01-30
•
Granted: 1975-04-01
•
Expires: 1994-01-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An apparatus for the isolation and concentration of microbial pathogens from a sample fluid which comprises an elongated enclosed centrifugation receptacle containing an evacuated space in contact with a sterile aqueous solution of a material having a greater density than the sample fluid but able to selectively receive microbial pathogens from the sample fluid, a first injectable closure on one end thereof and a second injectable closure on its other end, and a sterile end chamber in communication with the second injectable closure which contains a sample fluid treating solution together with an injection needle assembly which when actuated will pass through the second injectable closure means and allow communication between the chamber and the evacuated space within the centrifugation receptacle to thereby allow the treating fluid to flow from the chamber into the evacuated space. Thereafter, the sample fluid can be injected into the evacuated chamber of the centrifugation tube through a needle passing through the first injectable closure and allow the sample fluid to admix with the pretreating solution in the evacuated chamber. The article is then subjected to centrifugation to allow the microbial pathogens to selectively pass into the liquid filter medium.

Inventors

  • 👤 Gordon L Dorn
  • 👤 Joseph M Hill

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 07:58
CPC Classifications
B; B01; B01L; B01L3/00; B01L3/50; B01L3/508; B01L3/5082; Y; Y10; Y10S; Y10S215/00; Y10S215/03

Claims Analysis

Total Claims: 27
Claim 1
Independent Claim 179 words
An apparatus used for the isolation and concentration of microbial pathogens from a sample fluid comprising: a. an enclosed centrifugation receptacle having a first end and a second end and containing an evacuated space maintained at a lower than atmospheric pressure adjacent a sterile aqueous solution of a material which is non-toxic to said microbial pathogens and has a greater density than the sample fluid but able to selectively receive microbial pathogens from said sample fluid and also containing a minor effective amount of a thermally sensitive gelling agent; b. first injectable closure means sealably closing said first end of said elongated centrifugation receptacle; c. second injectable closure means sealably closing the second end of said elongated centrifugation receptacle; d. a sealed end chamber in alignment with said second injectable closure means on said second end of said elongated centrifugation receptacle and containing a sample treating fluid sealed therewithin; and e. injection needle means positioned within said sealed end chamber for passing said fluid from said end chamber through said second injectable closure means and into said evacuated space.
Claim 2
Independent Claim 179 words
An apparatus used for the isolation and concentration of microbial pathogens from a sample fluid comprising: a. an enclosed centrifugation receptacle having a first end and a second end and containing an evacuated space maintained at a lower than atmospheric pressure adjacent a sterile aqueous solution of a material which is non-toxic to said microbial pathogens and has a greater density than the sample fluid but able to selectively receive microbial pathogens from said sample fluid and also containing a minor effective amount of a thermally sensitive gelling agent; b. first injectable closure means sealably closing said first end of said elongated centrifugation receptacle; c. second injectable closure means sealably closing the second end of said elongated centrifugation receptacle; d. a sealed end chamber in alignment with said second injectable closure means on said second end of said elongated centrifugation receptacle and containing a sample treating fluid sealed therewithin; and e. injection needle means positioned within said sealed end chamber for passing said fluid from said end chamber through said second injectable closure means and into said evacuated space.
Claim 3
Dependent Claim 101 words
The apparatus of claim 1 wherein said injection needle means comprises a tubular stylus means positioned within said sealed end chamber in alignment with said second injectable closure means and containing a first opening adjacent its leading end and a second opening through the sidewall thereof at a spaced distance therefrom, and means to advance said stylus means toward said second injectable closure means to a fully advanced position such that the leading end thereof and said first opening passes through said second injectable closure means and into said evacuated space and the second opening thereof remains in said second chamber.
Claim 4
Dependent Claim 32 words
The apparatus of claim 2 wherein said end chamber is formed between said second injectable closure means and a hollow cap means detachably affixed to said second end of said centrifugation vessel.
Claim 5
Dependent Claim 20 words
The apparatus of claim 3 wherein said cap means is threadably engaged with said second end of said centrifugation vessel.
Claim 6
Dependent Claim 48 words
The apparatus of claim 4 wherein said tubular stylus depends from said cap means in alignment in said end chamber with said second injectable closure means and is advanced to its said extended position by rotating said threadably engaged cap on said second end of said centrifugation vessel.
Claim 7
Dependent Claim 27 words
The apparatus of claim 4 wherein said tubular stylus is positioned on a plunger means in said end chamber in alignment with said second injectable closure means.
Claim 8
Dependent Claim 29 words
The apparatus of claim 4 wherein said minor effective amount of said thermally sensitive gelling agent is from about 1 to about 5 wt % of said aqueous solution.
Claim 9
Dependent Claim 13 words
The apparatus of claim 7 wherein said thermally sensitive gelling agent is gelatin.
Claim 10
Dependent Claim 16 words
The apparatus of claim 8 wherein said aqueous solution is an aqueous solution of a sugar.
Claim 11
Dependent Claim 10 words
The apparatus of claim 9 wherein said sugar is sucrose.
Claim 12
Dependent Claim 18 words
The apparatus of claim 10 wherein said aqueous solution contains at least 40 wt % of said sucrose.
Claim 13
Dependent Claim 39 words
The apparatus of claim 8 wherein said aqueous solution is an aqueous solution of a macromolecular solute having microporous openings throughout its solubilized network, said openings being of sufficient size to selectively pass said pathogens from said sample fluid.
Claim 14
Dependent Claim 35 words
The apparatus of claim 12 wherein said polymer is epichlorohydrin-sucrose polymer having a molecular weight in a range of from about 300,000 to about 500,000 and a specific rotation ( Alpha )D20 of + 56.5*.
Claim 15
Dependent Claim 22 words
The apparatus of claim 12 wherein said polymer is dextran having a molecular weight of from about 10,000 to about 2,000, 000.
Claim 16
Independent Claim 291 words
A METHOD OF DETECTING MICROBIAL PATHOGEN IN A BODY FLUID COMPRISING: A. PROVIDING AN AQUEOUS FILTER SOLUTION BETWEEN FIRST AND SECOND INJECTABLE ZONES WITHIN A CENTRIFUGATION TUBE, SAID AQUEOUS FILTER SOLUTION CONTAINING A THERMALLY SENSITIVE GELLING AGENT AND BEING AN AQUEOUS SOLUTION OF MATERIAL WHICH IS NON-TOXIC TO SAID SAMPLE FLUID BUT ABLE TO SELEC0009 GREATER DENSITY THAN SAID SAMPLE FLUID BUT ABLE TO SELECTIVELY RECEIVE MICROBIAL PATHOGENS FROM SAID SAMPLE FLUID; B. POSTING SAID CONTRIFUGATION TUBE SUCH THAT SAID AQUEOUS FILTER SOLUTION RESTS ON SAID FIRST INJECTABLE ZONE AND THEREAFTER COOLING SAID CENTRIFUGATION TUBE TO CAUSE SAID THERMALLY SENSITIVE GELLING AGENT TO SOLIDIFY SAID AQUEOUS FILTER SOLUTION; C. DEPOSITING A TREATMENT FLUID FOR SAID BODY FLUID UPON SAID SOLIDIFIED AQUEOUS FILTER SOLUTION BY PASSING AN INJECTION NEEDLE THROUGH SAID SECOND INJECTABLE ZONE AND THEREAFTER INJECTING SAID SAMPLE TREATMENT FLUID INTO SAID CENTRIFUGATION TUBE AND UPON SAID SOLIDIFIED AQUEOUS FILTER SOLUTION; D. DEPOSITING A SAMPLE OF SAID BODY FLUID UPON SAID SOLIDIFIED AQUEOUS FILTER SOLUTION AND ADMIXING SAID BODY FLUID WITH SAID TREATMENT FLUID BY PASSING A HYPODERMIC NEEDLE THROUGH SAID FIRST INJECTABLE ZONE AND THROUGH SAID SOLIDIFIED AQUEOUS FILTER SOLUTION AND THEREAFTER INJECTING SAID BODY FLUID THROUGH SAID HYPODERMIC NEEDLE INTO SAID CENTRIFUGATION TUBE; E. HEATING SAID CENTRIFUGATION TUBE SUFFICIENTLY TO LIQUEFY SAID THERMALLY SENSITIVE GELLING AGENT AND THEREBY LIQUEFY AN AQUEOUS FILTER SOLUTION; F. SUBJECTING SAID CENTRIFUGATION TUBE TO CENTRIFUGATION IN A MANNER TO FORCE SAID SAMPLE OF BODY FLUID AGAINST SAID AQUEOUS FILTER SOLUTION AND CAUSE SAID MICROBIAL PATHOGENS TO SELECTIVELY PASS THEREIN AND THEREBY SEPARATE FROM THE RESIDUAL MASS OF SAID BODY FLUID SAMPLE AND SAID TREATING FLUID; AND G. SEPARATING SAID AQUEOUS FILTER SOLUTION CONTAINING SAID MICROBIAL PATHOGEN FROM SAID RESIDUAL MASS OF SAID BODY FLUID.
Claim 17
Independent Claim 291 words
A METHOD OF DETECTING MICROBIAL PATHOGEN IN A BODY FLUID COMPRISING: A. PROVIDING AN AQUEOUS FILTER SOLUTION BETWEEN FIRST AND SECOND INJECTABLE ZONES WITHIN A CENTRIFUGATION TUBE, SAID AQUEOUS FILTER SOLUTION CONTAINING A THERMALLY SENSITIVE GELLING AGENT AND BEING AN AQUEOUS SOLUTION OF MATERIAL WHICH IS NON-TOXIC TO SAID SAMPLE FLUID BUT ABLE TO SELEC0009 GREATER DENSITY THAN SAID SAMPLE FLUID BUT ABLE TO SELECTIVELY RECEIVE MICROBIAL PATHOGENS FROM SAID SAMPLE FLUID; B. POSTING SAID CONTRIFUGATION TUBE SUCH THAT SAID AQUEOUS FILTER SOLUTION RESTS ON SAID FIRST INJECTABLE ZONE AND THEREAFTER COOLING SAID CENTRIFUGATION TUBE TO CAUSE SAID THERMALLY SENSITIVE GELLING AGENT TO SOLIDIFY SAID AQUEOUS FILTER SOLUTION; C. DEPOSITING A TREATMENT FLUID FOR SAID BODY FLUID UPON SAID SOLIDIFIED AQUEOUS FILTER SOLUTION BY PASSING AN INJECTION NEEDLE THROUGH SAID SECOND INJECTABLE ZONE AND THEREAFTER INJECTING SAID SAMPLE TREATMENT FLUID INTO SAID CENTRIFUGATION TUBE AND UPON SAID SOLIDIFIED AQUEOUS FILTER SOLUTION; D. DEPOSITING A SAMPLE OF SAID BODY FLUID UPON SAID SOLIDIFIED AQUEOUS FILTER SOLUTION AND ADMIXING SAID BODY FLUID WITH SAID TREATMENT FLUID BY PASSING A HYPODERMIC NEEDLE THROUGH SAID FIRST INJECTABLE ZONE AND THROUGH SAID SOLIDIFIED AQUEOUS FILTER SOLUTION AND THEREAFTER INJECTING SAID BODY FLUID THROUGH SAID HYPODERMIC NEEDLE INTO SAID CENTRIFUGATION TUBE; E. HEATING SAID CENTRIFUGATION TUBE SUFFICIENTLY TO LIQUEFY SAID THERMALLY SENSITIVE GELLING AGENT AND THEREBY LIQUEFY AN AQUEOUS FILTER SOLUTION; F. SUBJECTING SAID CENTRIFUGATION TUBE TO CENTRIFUGATION IN A MANNER TO FORCE SAID SAMPLE OF BODY FLUID AGAINST SAID AQUEOUS FILTER SOLUTION AND CAUSE SAID MICROBIAL PATHOGENS TO SELECTIVELY PASS THEREIN AND THEREBY SEPARATE FROM THE RESIDUAL MASS OF SAID BODY FLUID SAMPLE AND SAID TREATING FLUID; AND G. SEPARATING SAID AQUEOUS FILTER SOLUTION CONTAINING SAID MICROBIAL PATHOGEN FROM SAID RESIDUAL MASS OF SAID BODY FLUID.
Claim 18
Dependent Claim 20 words
The method of claim 15 wherein said body fluid is blood and said treatment fluid comprises a blood lysing agent.
Claim 19
Dependent Claim 18 words
The method of claim 16 wherein said aqueous filter solution comprises an aqueous solution of a nonionic sugar.
Claim 20
Dependent Claim 11 words
The method of claim 17 wherein said nonionic sugar is sucrose.
Claim 21
Dependent Claim 21 words
The method of claim 17 wherein said aqueous filter solution contains at least about 40 wt % of said sugar therewithin.
Claim 22
Dependent Claim 41 words
The method of claim 16 wherein said aqueous filter solution comprises a sterile aqueous solution of a macromolecular solute having microporous openings throughout its solubilized network, said openings being of sufficient size to selectively pass said pathogens from said sample fluid.
Claim 23
Dependent Claim 44 words
The method of claim 20 wherein said aqueous filter solution comprises an aqueous solution of a copolymer of sucrose and epichlorohydrin which has a molecular weight in the range of from about 300,000 to 500,000 and a specific rotation ( Alpha )D20 of 56.6*.
Claim 24
Dependent Claim 21 words
The method of claim 21 wherein said aqueous solution contains from about 10 to about 40 weight percent of said copolymer.
Claim 25
Dependent Claim 27 words
The method of claim 20 wherein said aqueous filter solution comprises an aqueous solution of dextran which has a molecular weight from about 10,000 to about 2,000,000.
Claim 26
Dependent Claim 27 words
The method of claim 23 wherein said dextran is present in said aqueous solution in an amount ranging from about 10 to about 40 weight percent thereof.
Claim 27
Dependent Claim 35 words
The method of claim 16 further comprises thoroughly mixing said aqueous filter solution containing said microbial pathogens; plating at least portions of said admixed, aqueous filter solution on a growth media for said microbial pathogens.

References Cited (Backward Citations)

US2115731A Cited
US2159217A Cited
US2193322A Cited
US2590900A Cited
US3072538A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-03-31 1978-09-30 1979-04-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-03-31 1982-09-30 1983-04-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-03-31 1986-09-30 1987-04-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag